BFM
INBX

Boothbay Fund Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Boothbay Fund Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,247
Closed -$340K – 2953
2022
Q1 		$340K Hold
15,247
– – 0.01% 1535
2021
Q4 		$666K Sell
15,247
-13,971
-48% -$559K 0.02% 910
2021
Q3 		$973K Buy
+29,218
New +$889K 0.03% 777

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boothbay Fund Management's INBX Position: Q2 2022 in Review

Boothbay Fund Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2022, closing a stake of 15,247 shares — an estimated $340K sold.

Boothbay Fund Management first reported a position in INBX in Q3 2021 and held it in 3 quarters. The position peaked at $973K in Q3 2021. 100 funds tracked by Wall St. Rank hold INBX as of Q2 2022.

  • Boothbay Fund Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 15,247 Inhibrx, Inc. Common Stock shares in Q2 2022, an estimated $340K.
  • Boothbay Fund Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Boothbay Fund Management's Inhibrx, Inc. Common Stock position peaked at $973K in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.